sodium chloride + dextrose/demo (0.9+5)% w/v solution for intravenous infusion
the star medicines importers co. ltd (0000003109) 10 loukis akritas str, lemesos, 3030 - sodium chloride; dextrose monohydrate - solution for intravenous infusion - (0.9+5)% w/v - sodium chloride (0007647145) 9mg; dextrose monohydrate (8000001877) 55mg - carbohydrates/proteins/minerals/vitamins, comb.
sodium chloride/demo 0.9% w/v solution for intravenous infusion
demo s.a. (0000003568) 21st km national road athens-lamia, krioneri, attiki, 14568 - sodium chloride - solution for intravenous infusion - 0.9% w/v - sodium chloride (0007647145) 9g - sodium chloride
eyesalt sol.ocu.ir
ΚΟΠΕΡ Α.Ε. ΑΡΙΣΤΟΒΟΥΛΟΥ 64, 11853 Κ. ΠΕΤΡΑΛΩΝΑ 3462102 3462108 - sodium chloride; potassium chloride; calcium chloride dihydrate; magnesium chloride hexahydrate; sodium acetate trihydrate; sodium citrate dihydrate - sol.ocu.ir (ΔΙΑΛΥΜΑ ΓΙΑ ΕΝΔΟΦΘΑΛΜΙΑ ΕΚΠΛΥΣΗ) - sodium chloride 6,4mg; potassium chloride 0,75mg; calcium chloride dihydrate 0,48mg; magnesium chloride hexahydrate 0,3mg; sodium acetate trihydrate 3,9mg; sodium citrate dihydrate 1,7mg - other ophthalmologicals - other ophthalmologicals
lactated ringer΄s/demo (0.32+0.6+0.04+0.027)% w/v solution for intravenous infusion
the star medicines importers co. ltd (0000003109) 10 loukis akritas str, lemesos, 3030 - calcium chloride dihydrate; sodium chloride; sodium lactate; potassium chloride - solution for intravenous infusion - (0.32+0.6+0.04+0.027)% w/v - calcium chloride dihydrate (0010035048) 0,27mg; sodium chloride (0007647145) 6mg; sodium lactate (0000072173) 3,2mg; potassium chloride (0007447407) 0,4mg - electrolytes in comb with other drugs
sodium chloride/baxter(viaflo) 0.9% w/v solution for infusion
baxter (hellas) epe (0000008332) 47, marinou antypa & anafis str, n. herakleio-attiki, 141 21 - sodium chloride - solution for infusion - 0.9% w/v - sodium chloride (0007647145) 0,9% w/v - other i.v. solution additives
sodium chloride + dextrose/demo (0.18+4)% w/v solution for intravenous infusion
the star medicines importers co. ltd (0000003109) 10 loukis akritas str, lemesos, 3030 - dextrose monohydrate; sodium chloride - solution for intravenous infusion - (0.18+4)% w/v - dextrose monohydrate (8000001877) 44mg; sodium chloride (0007647145) 1,8mg - carbohydrates/proteins/minerals/vitamins, comb.
sodium chloride+dextrose/demo sol.inf (0,9+5)% (w/v)
demo abee 21 ΧΛΜ. ΕΘΝ.ΟΔΟΥ ΑΘΗΝΩΝ-ΛΑΜΙΑΣ, 145 68 145 68, ΚΡΥΟΝΕΡΙ 8161802 - sodium chloride; dextrose(glucose) monohydrate - sol.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ) - (0,9+5)% (w/v) - sodium chloride 9mg; dextrose(glucose) monohydrate 55mg - electrolytes with carbohydrates
sodium chloride+dextrose/demo sol.inf (0,18+4)% (w/v)
demo abee 21 ΧΛΜ. ΕΘΝ.ΟΔΟΥ ΑΘΗΝΩΝ-ΛΑΜΙΑΣ, 145 68 145 68, ΚΡΥΟΝΕΡΙ 8161802 - sodium chloride; dextrose(glucose) monohydrate - sol.inf (ΔΙΑΛΥΜΑ ΓΙΑ ΕΓΧΥΣΗ) - (0,18+4)% (w/v) - sodium chloride 1,8mg; dextrose(glucose) monohydrate 44mg - electrolytes with carbohydrates
pantoprazole sodium teva
teva pharma b.v., utrecht, the netherlands - pantoprazole sodium sesquihydrate - ΚΟΝΙΣ ΓΙΑ ΕΝΕΣΙΜΟ ΔΙΑΛΥΜΑ/ΔΙΑΛΥΜΑ ΠΡΟΣ ΕΓΧΥΣΗ - 40mg/vial - ineof00942 - pantoprazole sodium sesquihydrate - 42.400000 mg - pantoprazole
sitagliptin / metformin hydrochloride mylan
mylan ireland limited - sitagliptin hydrochloride monohydrate, metformin hydrochloride - Σακχαρώδης διαβήτης τύπου 2 - Φάρμακα που χρησιμοποιούνται στον διαβήτη - for adult patients with type 2 diabetes mellitus:sitagliptin/metformin hydrochloride mylan is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin. sitagliptin/metformin hydrochloride mylan is indicated in combination with a sulphonylurea (i. θεραπεία τριπλού συνδυασμού) ως επιπρόσθετο στη δίαιτα και την άσκηση σε ασθενείς που δεν ελέγχονται επαρκώς με μέγιστη ανεκτή για αυτούς δόση μετφορμίνης και σουλφονυλουρίας. sitagliptin/metformin hydrochloride mylan is indicated as triple combination therapy with a peroxisome proliferator-activated receptor gamma (pparg) agonist (i. , a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparg agonist. sitagliptin/metformin hydrochloride mylan is also indicated as add-on to insulin (i. , triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.